SCHEMBL29460686

SCHEMBL29460686

C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDCD1LG2 Q9BQ51 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
ECE1 P42892 5/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
PTGS2 P35354 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MMP8 P22894 1/20 0.38
MME P08473 3/20 0.38
PTGS1 P23219 1/20 0.36
GSTK1 Q9Y2Q3 1/20 0.36
GLO1 Q04760 1/20 0.35
ACE P12821 1/20 0.35
CPA1 P15085 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
PAX8 Q06710 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29785083 0.94 ECE1 (0.43) PDCD1LG2CD274ECE1ALDH1A1LMNA
SCHEMBL29351498 0.90 ALDH1A1 (0.47) ECE1ALDH1A1LMNAMAPTPTGS2
SCHEMBL29379914 0.88 PTGS1 (0.50) PDCD1LG2CD274ECE1ALDH1A1LMNA
SCHEMBL7575574 0.88 GLO1 (0.44) ECE1ALDH1A1LMNAMAPTPTGS2
SCHEMBL29744873 0.87 PDCD1LG2 (0.44) PDCD1LG2CD274ECE1ALDH1A1LMNA
SCHEMBL30116702 0.87 PTGS1 (0.40) PDCD1LG2CD274ECE1MMP8PTGS1
SCHEMBL30099477 0.87 ECE1 (0.40) PDCD1LG2CD274ECE1ALDH1A1LMNA
SCHEMBL29644351 0.87 PDCD1LG2 (0.44) PDCD1LG2CD274ECE1ALDH1A1LMNA
SCHEMBL7575589 0.86 GLO1 (0.44) ECE1ALDH1A1LMNAMAPTPTGS2
SCHEMBL31187794 0.84 ECE1 (0.51) PDCD1LG2CD274ECE1MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220105190-A1 METHODS OF USING GLYCOPOLYSIALYLATED THERAPEUTIC PROTEINS LIPOXEN TECHNOLOGIES LIMITED (US) 2022-04-07 US disclosed